4//SEC Filing
Kearney Michael J 4
Accession 0001737174-18-000002
CIK 0001718108other
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 2:38 PM ET
Size
9.2 KB
Accession
0001737174-18-000002
Insider Transaction Report
Form 4
October 2017 Liquidating Trust
10% Owner
Transactions
- Conversion
Common Stock
2018-04-23+406,113→ 406,113 total(indirect: See Footnote 2) - Conversion
Series A Preferred Stock
2018-04-23−893,450→ 0 total(indirect: See Footnote 2)→ Common Stock (406,113 underlying)
Kearney Michael J
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2018-04-23−893,450→ 0 total(indirect: See Footnote 2)→ Common Stock (406,113 underlying) - Conversion
Common Stock
2018-04-23+406,113→ 406,113 total(indirect: See Footnote 2)
Footnotes (2)
- [F1]On April 23, 2018, in connection with the completion of the issuer's initial public offering, each 2.2 shares of Series A Preferred Stock converted into 1 share of Common Stock.
- [F2]The shares of common stock of Surface Oncology, Inc. reported in this Form 4 are held by October 2017 Liquidating Trust (the "Trust"). Michael Kearney is the trustee and a beneficiary of the Trust and disclaims any beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned is the beneficial owner of all of the securities reported herein.
Documents
Issuer
Surface Oncology, Inc.
CIK 0001718108
Entity typeother
Related Parties
1- filerCIK 0001737627
Filing Metadata
- Form type
- 4
- Filed
- Apr 24, 8:00 PM ET
- Accepted
- Apr 25, 2:38 PM ET
- Size
- 9.2 KB